WELL Health Technologies (TSE:WEL – Get Free Report) was upgraded by stock analysts at Ventum Cap Mkts to a “strong-buy” rating in a report released on Thursday, Zacks.com reports. Ventum Cap Mkts also issued estimates for WELL Health Technologies’ Q3 2024 earnings at $0.00 EPS and Q4 2024 earnings at $0.02 EPS.
WELL Health Technologies Stock Performance
WELL Health Technologies (TSE:WEL – Get Free Report) last posted its quarterly earnings results on Wednesday, May 8th. The company reported C$0.08 earnings per share for the quarter, beating the consensus estimate of C($0.04) by C$0.12. The company had revenue of C$231.56 million for the quarter, compared to the consensus estimate of C$227.98 million.
Featured Stories
- Five stocks we like better than WELL Health Technologies
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Top 3 Beverage Stocks: Summer Earnings Reveal Key Trends
- What Investors Need to Know to Beat the Market
- This Financial Stock’s Earnings Signal a Buying Opportunity
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Social Platform Stock Hits New Highs: Is More Growth Ahead?
Receive News & Ratings for WELL Health Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WELL Health Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
